Full name :
First name :
Mail :
Zip Code :
City :
Country :
Email :
Phone :
Fax :
Website :
Directory :
| Title : Varenicline enhances dopamine release facilitation more than nicotine after long-term nicotine treatment and withdrawal - Perez_2015_Pharmacol.Res.Perspect_3_e00105 |
| Author(s) : Perez XA , Khroyan TV , McIntosh JM , Quik M |
| Ref : Pharmacol Res Perspect , 3 :e00105 , 2015 |
| Abstract : Perez_2015_Pharmacol.Res.Perspect_3_e00105 |
| ESTHER : Perez_2015_Pharmacol.Res.Perspect_3_e00105 |
| PubMedSearch : Perez_2015_Pharmacol.Res.Perspect_3_e00105 |
| PubMedID: 25692023 |
| Title : Poster: Antidyskinetic effect of the novel alpha7 nicotinic receptor agonist ABT-126 in parkinsonian monkeys - |
| Author(s) : McGregor M , Danhui Zhang D , Tanuja Bordia T , Perez XA , Decker MW , Quik M |
| Ref : Biochemical Pharmacology , 97 :629 , 2015 |
| PubMedID: |
| Title : Role for the nicotinic cholinergic system in movement disorders\; therapeutic implications - Quik_2014_Pharmacol.Ther_144_50 |
| Author(s) : Quik M , Zhang D , Perez XA , Bordia T |
| Ref : Pharmacol Ther , 144 :50 , 2014 |
| Abstract : Quik_2014_Pharmacol.Ther_144_50 |
| ESTHER : Quik_2014_Pharmacol.Ther_144_50 |
| PubMedSearch : Quik_2014_Pharmacol.Ther_144_50 |
| PubMedID: 24836728 |
| Title : Long-term nicotine treatment down-regulates alpha6beta2* nicotinic receptor expression and function in nucleus accumbens - Perez_2013_J.Neurochem_127_762 |
| Author(s) : Perez XA , McIntosh JM , Quik M |
| Ref : Journal of Neurochemistry , 127 :762 , 2013 |
| Abstract : Perez_2013_J.Neurochem_127_762 |
| ESTHER : Perez_2013_J.Neurochem_127_762 |
| PubMedSearch : Perez_2013_J.Neurochem_127_762 |
| PubMedID: 23992036 |
| Title : Nicotine-mediated improvement in L-dopa-induced dyskinesias in MPTP-lesioned monkeys is dependent on dopamine nerve terminal function - Quik_2013_Neurobiol.Dis_50_30 |
| Author(s) : Quik M , Mallela A , Chin M , McIntosh JM , Perez XA , Bordia T |
| Ref : Neurobiol Dis , 50 :30 , 2013 |
| Abstract : Quik_2013_Neurobiol.Dis_50_30 |
| ESTHER : Quik_2013_Neurobiol.Dis_50_30 |
| PubMedSearch : Quik_2013_Neurobiol.Dis_50_30 |
| PubMedID: 23009753 |
| Title : Long-term nicotine exposure depresses dopamine release in nonhuman primate nucleus accumbens - Perez_2012_J.Pharmacol.Exp.Ther_342_335 |
| Author(s) : Perez XA , Ly J , McIntosh JM , Quik M |
| Ref : Journal of Pharmacology & Experimental Therapeutics , 342 :335 , 2012 |
| Abstract : Perez_2012_J.Pharmacol.Exp.Ther_342_335 |
| ESTHER : Perez_2012_J.Pharmacol.Exp.Ther_342_335 |
| PubMedSearch : Perez_2012_J.Pharmacol.Exp.Ther_342_335 |
| PubMedID: 22562772 |
| Title : Nicotine as a potential neuroprotective agent for Parkinson's disease - Quik_2012_Mov.Disord_27_947 |
| Author(s) : Quik M , Perez XA , Bordia T |
| Ref : Movement Disorders , 27 :947 , 2012 |
| Abstract : Quik_2012_Mov.Disord_27_947 |
| ESTHER : Quik_2012_Mov.Disord_27_947 |
| PubMedSearch : Quik_2012_Mov.Disord_27_947 |
| PubMedID: 22693036 |
| Title : Focus on alpha4beta2* and alpha6beta2* nAChRs for Parkinson's Disease Therapeutics - Perez_2011_Mol.Cell.Pharmacol_3_1 |
| Author(s) : Perez XA , Quik M |
| Ref : Mol Cell Pharmacol , 3 :1 , 2011 |
| Abstract : Perez_2011_Mol.Cell.Pharmacol_3_1 |
| ESTHER : Perez_2011_Mol.Cell.Pharmacol_3_1 |
| PubMedSearch : Perez_2011_Mol.Cell.Pharmacol_3_1 |
| PubMedID: 21499569 |
| Title : Targeting nicotinic receptors for Parkinson's disease therapy - Quik_2011_CNS.Neurol.Disord.Drug.Targets_10_651 |
| Author(s) : Quik M , Bordia T , Huang L , Perez XA |
| Ref : CNS Neurol Disord Drug Targets , 10 :651 , 2011 |
| Abstract : Quik_2011_CNS.Neurol.Disord.Drug.Targets_10_651 |
| ESTHER : Quik_2011_CNS.Neurol.Disord.Drug.Targets_10_651 |
| PubMedSearch : Quik_2011_CNS.Neurol.Disord.Drug.Targets_10_651 |
| PubMedID: 21838678 |
| Title : Role of alpha6 nicotinic receptors in CNS dopaminergic function: relevance to addiction and neurological disorders - Quik_2011_Biochem.Pharmacol_82(8)_873 |
| Author(s) : Quik M , Perez XA , Grady SR |
| Ref : Biochemical Pharmacology , 82 :873 , 2011 |
| Abstract : Quik_2011_Biochem.Pharmacol_82(8)_873 |
| ESTHER : Quik_2011_Biochem.Pharmacol_82(8)_873 |
| PubMedSearch : Quik_2011_Biochem.Pharmacol_82(8)_873 |
| PubMedID: 21684266 |
| Title : alpha6ss2* and alpha4ss2* nicotinic receptors both regulate dopamine signaling with increased nigrostriatal damage: relevance to Parkinson's disease - Perez_2010_Mol.Pharmacol_78_971 |
| Author(s) : Perez XA , Bordia T , McIntosh JM , Quik M |
| Ref : Molecular Pharmacology , 78 :971 , 2010 |
| Abstract : Perez_2010_Mol.Pharmacol_78_971 |
| ESTHER : Perez_2010_Mol.Pharmacol_78_971 |
| PubMedSearch : Perez_2010_Mol.Pharmacol_78_971 |
| PubMedID: 20732972 |
| Title : Prominent role of alpha3\/alpha6beta2* nAChRs in regulating evoked dopamine release in primate putamen: effect of long-term nicotine treatment - Perez_2009_Mol.Pharmacol_75_938 |
| Author(s) : Perez XA , O'Leary KT , Parameswaran N , McIntosh JM , Quik M |
| Ref : Molecular Pharmacology , 75 :938 , 2009 |
| Abstract : Perez_2009_Mol.Pharmacol_75_938 |
| ESTHER : Perez_2009_Mol.Pharmacol_75_938 |
| PubMedSearch : Perez_2009_Mol.Pharmacol_75_938 |
| PubMedID: 19144785 |
| Title : Multiple roles for nicotine in Parkinson's disease - Quik_2009_Biochem.Pharmacol_78(7)_677 |
| Author(s) : Quik M , Huang LZ , Parameswaran N , Bordia T , Campos C , Perez XA |
| Ref : Biochemical Pharmacology , 78 :677 , 2009 |
| Abstract : Quik_2009_Biochem.Pharmacol_78(7)_677 |
| ESTHER : Quik_2009_Biochem.Pharmacol_78(7)_677 |
| PubMedSearch : Quik_2009_Biochem.Pharmacol_78(7)_677 |
| PubMedID: 19433069 |
| Title : Nicotine neuroprotection against nigrostriatal damage: importance of the animal model - Quik_2007_Trends.Pharmacol.Sci_28_229 |
| Author(s) : Quik M , O'Neill M , Perez XA |
| Ref : Trends in Pharmacological Sciences , 28 :229 , 2007 |
| Abstract : Quik_2007_Trends.Pharmacol.Sci_28_229 |
| ESTHER : Quik_2007_Trends.Pharmacol.Sci_28_229 |
| PubMedSearch : Quik_2007_Trends.Pharmacol.Sci_28_229 |
| PubMedID: 17412429 |